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AbstrAct
Objectives To explore the cost-effectiveness of a 
supervised moderate-to-high intensity aerobic exercise 
programme in people diagnosed with Alzheimer’s disease 
(AD) and estimate incremental cost-effectiveness ratios 
(ICER) using participant-reported and proxy-reported 
measures of health-related quality of life (HRQoL)
Design A cost-effectiveness analysis of economic and 
HRQoL data from a randomised trial delivered over 
16 weeks.
Setting Memory clinics in Denmark.
Participants 200 individuals with mild AD aged 50–
90 years gave informed consent to participate in the study. 
Participants were randomised to control or intervention 
group.
Interventions Control group received treatment as usual. 
The intervention group performed 1 hour of supervised 
moderate-to-high intensity aerobic exercise three times 
weekly for 16 weeks.
Primary and secondary outcomes measures Different 
physical, functional and health measures were obtained 
at inclusion (baseline) and 4 and 16 weeks after. HRQoL 
(EuroQol-5 Dimensions-5 Levels/EQ-Visual Analogue 
Scale) was reported by the participants and the primary 
caregivers as proxy respondents. Differences in HRQOL as 
reported by the participant and caregiver were explored as 
were different values of caregiver time with respite from 
care tasks.
Results The intervention cost was estimated at €608 
and €496 per participant, with and without transport cost, 
respectively. Participants and caregivers in the intervention 
group reported a small, positive non-significant 
improvement in EQ-5D-5L and EQ-VAS after 16 weeks. The 
ICER was estimated at €72 000/quality-adjusted life year 
using participant-reported outcomes and €87000 using 
caregiver-reported outcomes.
Conclusions The findings suggest that the exercise 
intervention is unlikely to be cost-effective within the 
commonly applied threshold values. The cost of the 
intervention might be offset by potential savings from 
reduction in use of health and social care.
Trial registration number https:// clinicaltrials. gov/ ct2/ 
show/ NCT01681602.
Background
Dementia is a group of common chronic brain 
diseases with over 80 000 cases in Denmark. 
This figure is projected to rise to over 140 000 
over the next 30 years.1 Alzheimer’s disease 
(AD) is the most common cause of dementia 
and is characterised by memory problems, 
other cognitive impairments, and loss of daily 
functioning. The disease is progressive and 
has very serious physical and mental health 
implications for participants and caregivers, 
as well as significant socioeconomic impact, 
since most individuals with AD will need help 
and support from family members and from 
the public system.
Physical exercise may improve cognition, 
physical performance, functional ability and 
health-related quality of life (HRQoL) in 
people diagnosed with AD.2–5 Physical exer-
cise, in particular, aerobic and resistance 
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Research
Strengths and limitations of this study
 ► This study uses data from a well-designed 
randomised controlled trial with near-complete data.
 ► In this study, we investigate whether using 
EuroQol-5 Dimensions or EQ-Visual Analogue Scale 
has an impact of the cost-effectiveness of such an 
intervention using well-established methods.
 ► The study had relatively short follow-up period and 
did not include cost consequences of health and 
social care used by the participants.
 ► The study contributes to the discussion on whether 
health-related quality of life should be completed by 
patients or caregiver (as a proxy).
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training in people with mild cognitive impairment has 
been shown to be cost-effective through reduction in 
healthcare use.6
Economic evaluation of physical exercise is challenging, 
as is evaluation of interventions aimed at individuals diag-
nosed with dementia. Some of these challenges relate 
to the measurements of outcomes or utilities. Measure-
ment of utilities using the EuroQol-5 Dimension system 
(EQ-5D)7 is a frequently used standardised approach.8 
However, one challenge facing such applications is that 
outcomes from interventions might not be measurable 
by the relatively crude instrument and outcomes may 
encompass other aspects than are included in the five 
dimensions of the instrument.
A further challenge arises with self-completion of health 
outcome measures. Completion of the EQ instrument is 
simple and many people find it an easy task. However, 
interpretation of health outcome measures completed by 
individuals with dementia may be more complicated as 
the disease may impair the respondents’ cognitive func-
tion and thereby impair the validity of the responses.9 It 
is possible to avoid this problem by asking the caregiver 
of participants with dementia to act as proxy respondents 
and complete the outcome measurements on behalf of 
or as supplement to the participant-completed measure-
ment.10 However, use of proxy-completed outcome 
measures may not fully reflect the patients’ health-related 
quality of life (HRQoL) due to lack of first-hand experi-
ence.
In addition to the challenges of assessing the cost-ef-
fectiveness of physical interventions of individuals with 
dementia, some interventions may also produce positive 
externalities in the form of improved outcomes for the 
caregivers. That could be the case if an intervention 
gave the primary caregiver some respite from the caring 
responsibility. Such respite would arise if the individual 
with dementia was taken care of in another regimen 
on a regular basis (eg, a couple of hours a few times 
per week). In such cases, a discussion of whether such 
respite from care should be included and valued in an 
economic evaluation, and if so, to what extent, is perti-
nent.
The objective of this study was to explore issues relating 
to the assessment of cost-effectiveness of the interven-
tion and estimate incremental cost-effectiveness ratios 
(ICER) using participant and proxy reported measures 
of HRQoL.
MeThod
Trial design
This study uses cost and HRQoL data from a previously 
published randomised trial.11 The primary outcomes of 
the 16-week follow-up period from baseline in cognitive 
performance (measured by Symbol Digit Modalities Test 
(SDMT)) and secondary outcomes as changes in other 
cognitive measures, quality of life, abilities to perform 
daily activities of daily living and neuropsychiatric and 
depressive symptoms have been reported,12 as well as the 
effect on physical performance.13
Briefly, the trial entitled ‘Preserving Cognition, Quality 
of Life, Physical Health and Functional Ability in Alzhei-
mer’s disease: the Effect of Physical Exercise (ADEX)’ was 
a multi-centre randomised trial conducted In Denmark 
between January 2012 and June 2014. Participants with 
mild AD (Mini-Mental State Examination (MMSE) 
score≥20) aged between 50 and 90 years were randomised 
to a control group that received treatment as usual, or 
an intervention group which performed 1 hour of super-
vised moderate-to-high intensity aerobic exercise three 
times weekly for 16 weeks.
The intervention exercises were conducted in groups 
of 2–5 participants, supervised by an experienced phys-
iotherapist. The first 4 weeks aimed at building strength 
of the lower extremities and introduced aerobic exer-
cise. The remaining 12 weeks, participants performed 
aerobic training on bicycle, cross trainer and treadmill. 
The target intensity was 70%–80% of maximal heart rate. 
The control group received treatment as usual, and was 
offered a 4-week adaptation exercise programme after 
the termination of the study.
The study was approved by the Danish National 
Committee on Biomedical Research Ethics (reference 
number H-3-2011-128) and by the Danish Data Protec-
tion Agency (J No. 30–0718).
overview of the cost-utility study
We used the Danish healthcare perspective and included 
the time use of participants as complementary outcome 
description. The analysis was restricted to a 16-week time 
horizon.
Health outcomes
Relevant measures of outcomes for this cost-utility 
analysis included the Danish version of EQ-5D-5L 
and EQ-Visual Analogue Scale (VAS).7 The instru-
ment was administered to both the participants and 
their caregivers as proxy respondents. The available 
EQ measurements included data from baseline and 
16 weeks completed by participants and caregivers 
in control and intervention groups. The descriptive 
categories of the EQ-5D-5L were converted to utilities 
using the available international scoring algorithm.14 
We calculated quality-adjusted life years (QALYs) for 
each individual participant using the participant and 
proxy-respondent scores.
Cost outcomes
Costs related to the intervention were recorded monthly 
for each individual, and were based on participants’ 
compliance with the training programme as recorded by 
the physiotherapist responsible for the group training. 
The questionnaires administered to participants and care-
givers recorded the time spent at the training sessions by 
the participants and their caregivers, as well as the mode 
and cost of transport to and from the sessions.
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The estimation of average cost per participant was 
conducted by a top-down and bottom-up approach. 
The top-down approach costed staff resources allocated 
to each memory clinic during for the whole project 
using standard salaries. The cost of participants’ trans-
portation was obtained as records made in the memory 
clinics’ accounting systems. In addition, the participants’ 
fees paid to the clinic from the project were assumed to 
cover the cost of the training facilities and ancillary staff. 
The bottom-up cost assumed a cost per training session 
attended estimated based on an hourly group training 
session with four participants and average cost for clinic 
organised transport of participants.
We calculated the total programme cost for the full 
programme and estimated the average cost per partici-
pant (top-down) and the individual cost using the average 
cost per attended training session (bottom-up).
Participants’ and accompanying persons’ time use was 
estimated as the duration of the training (60 min) with 
addition of 30 min for preparation and changing before 
and after the training and 30 min transport.
The cost analysis excluded the value of participants’ 
and caregivers’ time, their private transport costs and 
other private costs. The cost analysis also excluded poten-
tial costs relating to accidents/adverse events during the 
training sessions and changed demand for healthcare—
for example, in primary and social care.
Costs were collected and recorded in 2015 Danish 
Crowns (DKK) and are reported in 2015 Euro (€) 
(€1=7.46 DKK). Discounting was not applied due to the 
short 16-week time frame.
Missing data
Missing data were not a serious problem. For five partic-
ipants, the number of attended training sessions was 
missing and replaced with the relevant 4-week period 
mean of the available data. Mode of transport was 
missing for 31 out of 3966 training sessions (0.7%) and 
was assumed to use other transport. Ten participants did 
not provide valid EQ-VAS or EQ-5D-5L at follow-up. No 
replacement was made for these data. Logistic regres-
sion did not identify any characteristics with statistical 
significant differences between those with and without 
follow-up EQ-data.
analyses
The average number of hours spent on exercise was esti-
mated based on the data reported by the physiotherapist. 
Participants completing the entire exercise programme 
with high intensity were analysed separately as a per-pro-
tocol group.
Use of caregivers’ time was obtained from the 
self-completed questionnaires where it was indicated 
whether the participant attended the exercise group 
accompanied by the caregiver. Mode of transport was 
also obtained from the questionnaires and was used 
to estimate the total time of transport. Although 
different cost estimates were available, the analyses 
reported here used only the direct cost of the training 
programme excluding transport costs. This was the 
lowest cost estimate and the other estimates would 
provide higher cost-effectiveness ratios than reported 
here. The choice of the lowest cost estimate may be 
justified as a realistic assessment of the resource 
use when the intervention is provided on a routine 
basis and in particular if the training is provided by 
private organisations with agreement by the municipal 
purchasing authorities.
The available EQ-data were analysed using both the 
participants’ and caregivers’ assessment. Differences at 
baseline were assessed by graphical box plots and esti-
mated association between assessments. The Pearson 
correlation coefficient between the participant and 
caregiver assessment was estimated separately for the 
control and exercise group. Variables were assessed 
for normality using visual examination and the Shap-
iro-Wilk test. In addition, the difference in health 
status between the baseline and follow-up assessment 
by the participants were assessed graphically and by 
Pearson correlation coefficients. Analysis of the raw 
EQ-data was conducted using parametric mean values 
and the associated 95% CIs. Baseline differences 
between groups were estimated using ordinary least 
squares (OLS) regression with dummy variables for 
the exercise group or caregiver as only independent 
variables.
Difference-in-difference estimates were also based 
from OLS regression. Three types of estimations were 
made: measures of incremental changes (=follow-up—
baseline) with exercise group as the only independent 
variable, with baseline scores as an additional variable 
and with a number of social variables (gender, age, civil 
status, MMSE score, Hamilton’s Depression score and 
two physical scores).
Incremental cost-effectiveness ratios were calculated 
using the baseline-adjusted estimates for EQ-5D-5L. Bias 
corrected and accelerated bootstrap methods were used 
to derive 1000 sets of estimates for incremental cost and 
EQ measures. These estimates where used to construct 
cost-effectiveness acceptability curves (CEAC) showing 
the probability of the exercise intervention being more 
cost-effective than the controls for different maximum 
levels that the decision makers may be willing to pay for 
an additional QALY.
CEACs were estimated using the subsample of partici-
pants who had been compliant with the intervention in 
comparison with the control group.
To assess the potential consequences of assigning 
different values of respite time values within the range 
of €0–€10 per hour was used. In this assessment, the 
net cost of the exercise was estimated by deducting the 
value of the time that the participant attended the exer-
cise programme (including preparation and transport).
Stata V.14.1 was used for all analyses. p Values <0.05 were 
considered statistically significant.
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resulTs
Participants
A total 608 potential participants were assessed for eligi-
bility in the duration of the programme. Of those, 104 did 
not meet the inclusion criteria, 107 declined to partici-
pate and a further 197 had transport problems or were 
excluded for other reasons. A total 200 individuals were 
randomised to the intervention group (n=107) or the 
control group (n=93) (see online supplementary table 1). 
After 16 weeks, 102 from the intervention group and 88 
from the control group provided data for the duration of 
the study, resulting in a loss to follow-up of five from each 
groups.12 There were no statistical significant differences 
in baseline characteristics between the two randomised 
groups.12 The drop-out rate was 4% and 8% for the inter-
vention and control groups, respectively.12
Of the 200 randomised participants, 57% were male. 
Mean age was 70.02 (SD 7.41) years and the mean MMSE 
score was 23.96 (SD 3.59). Of the 107 participants in the 
intervention group, 76% attended more than 80% of the 
exercise sessions and 78% (n=66; analysed as a per-pro-
tocol group) exercised with an intensity of more than 
70% of the maximal heart rate.12 No significant differ-
ences in background characteristics could be found 
between participants in the control group and the low-in-
tensity and high-intensity exercise group.12
resource use and cost outcomes
Participant time
During the 16-week period, the group of 107 partic-
ipants in the exercise group had in total 3966 training 
sessions and used in total 7932 hours on participating in 
the programme. That corresponds to an average of 37 
training sessions (median 41; max 47) and 74 hours of 
training, change and transport (median 82 hours, max 
94 hours). Forty-nine of the participants arrived to the 
training with an accompanying person, and they used in 
total 2120 hours corresponding to 43 hours per accompa-
nied participant or 20 hours per participant. The average 
time used for participants at different memory clinics is 
presented in online supplementary figure 1.
Top-down cost
Each Memory Clinic were allocated financial coverage 
of 0.5 full-time equivalent (FTE) physiotherapist, and 
0.6/0.75 FTE nurse from research programme. The 
clinics funded the transport cost for the participants who 
required transport assistance (~€80 000) out of their 
own budget. In addition, the clinics were paid from the 
research programme €135  per active participant per 
4-week training. The total programme cost was estimated 
at €429 000  resulting in an average programme cost per 
participant at €3990.
Bottom-up cost
Assuming that one physiotherapist provided 1 hour 
training group sessions with four participants, the average 
cost per participant per session was estimated at €13. 
Hospital-provided transport cost was estimated at €82 per 
participant per session (970 sessions).
The average incremental cost for participants in the 
exercise group was estimated at 608 (95% CI 604 to 612) 
and 496  (95% CI 495 to 497) with and without transport 
cost, respectively.
eQ measurements
Baseline and follow-up (16-week) measurements were 
reported by participants and their caregivers and were 
measured using EQ-5D-5L and EQ-VAS. At baseline, all 
participants (control and intervention) reported a mean 
score of 0.929 (95% CI 0.916 to 0.942) and 83.2 (95% 
CI 81.2 to 85.3), as measured by EQ-5D-5L and EQ-VAS, 
respectively. Caregivers reported a mean score of 0.864 
(95% CI 0.847 to 0.882) and 73.7 (95% CI 71.2 to 76.2). 
No statistically significant baseline difference was found 
between the control and exercise groups for any of the 
measurements.
The intervention yielded a statistically significant 
increase over time in EQ-VAS assessed by the caregiver 
(3.8; 95% CI 0.2 to 7.4), indicating a 3.8 point improve-
ment (on a 100-point scale) in caregiver-completed 
HRQoL measure. All other measures indicated insig-
nificant positive changes 16 weeks after the baseline 
measurement with the change scores for the exercise 
group being consistently larger than for the control 
group. An overview of baseline and follow-up EQ-5D-5L 
and EQ-VAS measurements by participants and caregivers 
is presented in online supplementary figure 2.
The correlation between participant-reported and care-
giver-reported quality of life as measured by EQ-5D-5L 
and EQ-VAS is presented in figure 1. The black lines indi-
cate identical health status assessment, while points below 
the black line indicate that the caregiver is assessing the 
participants’ health status worse than the participants 
themselves. The blue and red lines correspond to the 
estimated relationship (linear regression) between partic-
ipants’ and caregivers’ assessment in the control and 
exercise group. Using the EQ-5D-5L, 54% of the care-
givers reported a worse health state than the participants 
at both baseline and after 16 weeks, while 26%–29% indi-
cated similar and 17% and 19% indicated better health 
states. Using the EQ-VAS the caregiver’s assessments 
were worse than the participant’s in 62% and 68% of 
the cases and better in 26% and 23% of the cases. The 
estimated correlation coefficients were 0.29 (p<0.001) 
and 0.24 (p<0.001) for baseline and 16-week assess-
ments, respectively, for EQ-5D-5L, Correlations were 
weaker for EQ-VAS, resulting in correlation coefficients 
of 0.16 (p<0.001) and 0.19 (p<0.001) at baseline and 
16 weeks, respectively.
The change over time in participants’ measurements is 
illustrated in figure 2. The black line indicates identical 
health status assessment at baseline and 16 weeks after. 
Points above the black line indicate that the participants 
reported better 16 weeks health status than at baseline. 
The blue and red lines correspond to the estimated 
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Figure 1 Correlation between participants’ and caregivers’ assessment of baseline EQ-VAS and EQ-5D-5L converted to index 
values. EQ-5D-5L, EuroQol-5 Dimensions-5 Levels; EQ-VAS, EQ Visual Analogue Scale.
Figure 2 Correlation between participants’ baseline and 16-week follow-up assessment of EQ-VAS and EQ-5D-5L health 
status converted to index values. EQ-5D-5L, EuroQol-5 Dimensions-5 Levels; EQ-VAS, EQ Visual Analogue Scale.
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Figure 3 Scatter plot ICER using participant reported EQ-index. EQ, EuroQoL; ICER, incremental cost-effectiveness ratios.
relationship (linear regression) between participants’ 
assessment at baseline and at 16-week follow-up. It appears 
that the correlation between the participant-reported 
measurements are stronger correlated with the EQ-5D-5L 
(0.59, p<0.001) than the EQ-VAS (0.51, p<0.001), and 
that the correlation is stronger for the exercise group 
than the control group (0.72 (p<0.001) vs 0.41 (p<0.001) 
(EQ-5D-5L)).
eQ difference-in-differences
Four baseline-adjusted estimates for difference-in-differ-
ences were estimated using the EQ-5D-5L utility index 
and the EQ-VAS as provided by the participants and 
proxy respondents. The participant assessed EQ-5D-5L 
difference was estimated at 0.002 (95% CI 0.005 to 0.009; 
p=0.59) and the proxy assessed difference at 0.005 (95% 
CI 0.004 to 0.014; p=0.24) which does not indicate 
support for utility gains from the intervention. Using the 
EQ-VAS score, the participants’ assessment indicated a 
difference of 0.62 (95% CI 0.61 to 1.85; p=0.33) and 0.45 
(95% CI 0.88 to 1.77; p=0.51) when using the caregivers’ 
assessment. Estimations adjusting for baseline score, 
demographic, social and health characteristics provided 
slightly larger, but still insignificant differences.
Incremental cost-utility ratio
Using the participant assessed EQ utility index and cost 
excluding transport costs the ICER was estimated at 
€158 520/QALY and 120 790 using the proxy-reported 
EQ-5D-5L index.
Using the EQ-VAS the ICER was estimated at €72 120/
QALY using participants’ EQ-VAS-5D and €87 157/QALY 
using the caregivers’ EQ-VAS. The scatter plot of the 
participant-reported EQ-5D-5L is illustrated in figure 3.
The cost-effectiveness acceptability curve using the 
four different measures of health is illustrated in figure 4. 
There is a 50% chance of the intervention being cost-ef-
fective using participant EQ-5D-5L at the threshold 
value of €175 000/QALY. With the participant-reported 
EQ-VAS, the threshold value is reduced to €75 000 . When 
using caregivers’ scores on both EQ-5D-5L and EQ-VAS, 
threshold values lie between €120 000 and €70 000, 
respectively.
As previously described, adherence to exercise protocol 
was achieved by 66 participants. When we restricted the 
analysis to these individuals (ie, per-protocol analysis), 
the cost-effectiveness acceptability curves shift (figure 5). 
Both participant-reported threshold values are lower than 
caregiver-reported results. Further, both caregiver and 
participant EQ-5D-5L measures resulted in higher thresh-
olds than VAS measures. With increased adherence to 
protocol, both EQ-5D-5L and EQ-VAS measures by partic-
ipants yielded a lower threshold than for all participants.
The exercise programme provided caregivers with 
respite from caregiver tasks. We considered a range of 
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Figure 4 Cost-effectiveness acceptability curve using different measures of health status index. Based on data from intention-
to-treat analysis. EQ-5D-5L, EuroQol-5 Dimensions-5 Levels; EQ-VAS, EQ Visual Analogue Scale.
Figure 5 Cost-effectiveness acceptability curve comparing participants with high-intensity exercise (n=66) with controls. 
Based on data from per-protocol analysis. EQ-5D-5L, EuroQol-5 Dimensions-5 Levels; EQ-VAS, EQ Visual Analogue Scale.
values of this free time—from €0 to €10/hour. Figure 6 
demonstrates the probability of the intervention being 
cost-effective (with quality of life measured by the 
participant-reported EQ-5D-5L) across this range. The 
intervention is considered cost saving when we value the 
caregiver time above €10/hour.
dIscussIon
In the general population, physical activity may have 
a positive impact on health and health-related quality of 
life. Physical activity may also provide important health 
impacts to people diagnosed with dementia.15 Having 
established positive relations to health, it becomes 
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Figure 6 Sensitivity analysis with different values of caregivers’ respite time.
relevant to consider whether certain interventions can 
ensure that more people with dementia become physi-
cally active. Therefore, it is relevant to assess whether such 
interventions actually improve the health of these people 
(and their caregivers). It is also relevant to investigate 
whether such interventions are ‘worth it?’.16 17 A number 
of economic evaluations have already been conducted 
and summarised in systematic reviews.18 However, 
economic evaluation of interventions aimed at changing 
behaviour in the elderly population is challenging.19 In 
particular, challenges lie in ensuring reasonable compli-
ance with the intervention programme, defining valid 
outcome measures and acquiring realistic assessments of 
such outcome measures. In addition, a discussion of who 
may benefit from the intervention arises. Clearly, if high 
compliance can be achieved, the participants may benefit 
from both the process and outcomes, but benefits of an 
intervention may also extend to participants’ caregivers. 
That may indeed be the case with people with AD, where 
the informal caregiver may perceive temporary relief 
from the tasks of caring for the participant.
This cost-utility study was based on a carefully 
designed and conducted clinical trial of providing an 
intensive physical training intervention programme to 
people with mild AD. For the application in the cost-
utility analysis, standard measures of resource use and 
health outcomes were collected from each participant. 
These data were analysed according to current analyt-
ical standards. However, it became clear that some 
methodological choices have impacts on the results. 
Thus, the standard assessment of the cost-effectiveness 
of the intervention provided an ICER of €160 000/
QALY, which is clearly not very attractive but also not 
without the reach of providing ‘good value for money’ 
in a Danish context.
challenges for the Icer result
It is clear that the ICER depends on the incremental cost 
and outcomes, and, indeed, the time frame that these are 
considered.
Cost
The cost analysis included the programme cost but 
disregarded potential consequences in the demand for 
health and social services. The time perspective of such 
data collection for further cost analysis would ideally be 
longer term (eg, 12 months after the intervention began). 
However, given the age group and nature of the disease 
there could have been expected a considerable deterio-
ration in the health states of participants and a relatively 
high risk of mortality. As healthcare cost increase with 
proximity to death, there would be strong concerns of the 
validity of the association of potential cost differences and 
the intervention. The cost analysis in this study is depen-
dent on the nature of this exercise intervention, and a 
different intensity or frequency of exercise may have 
yielded a different cost result.
Several other cost items could have been included. 
Complications or accidents due to the physical exercise 
intervention would be one that potentially would increase 
the cost of the exercise group. A few accidents and other 
complications appeared during the study period.(7) Some 
minor adverse events were likely related to the interven-
tion, that is, musculoskeletal problems, but only one 
serious adverse event (atrial fibrillation) was possible 
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linked to the intervention. The statistical power of the 
study was probably too weak to accurately identify such 
complications and their cost consequences due to the 
intervention.
Another cost aspect that was considered was a reduction 
in the demand of social services and delays in movement 
to nursing home. The hypothesis was that participants 
in the exercise group could remain more self-sufficient 
at their homes for longer time. If such hypothesis was 
true, that would mean that the intervention would be 
able to provide potential cost saving to the municipal 
social service and nursing home provision. However, 
the collection of municipal service data would require 
a considerable effort as such data are not collected in a 
standardised way or recorded in national databases. The 
movement into nursing homes was considered collected 
by phone contacts to the caregivers. However, such indi-
cators would not only indicate effect of the intervention 
but are also influences of the local capacity and demand 
for nursing home, and are thus heavily influenced by 
organisational factors in the different municipalities. 
Interpretation of differences in (time to) move to nursing 
homes was therefore perceived to be a weak indicator 
although in principle relevant.
In the cost-utility calculation, a simple measure of the 
intervention cost was used dependent on the number of 
training sessions each participant attended and an associ-
ated unit cost. The top-down costing analysis provided a 
much higher average cost estimate, but part of the funded 
resources were used to plan and conduct the evaluation 
and would therefore not be relevant for the cost-utility 
estimates.
Outcome measurements by the EQ instrument
The EQ instrument has been assessed for applications 
with people diagnosed with dementia.20–23 A recent study 
concluded that the EQ-5D-5L might have advantages 
over dementia-specific measures such as DEMQoL and 
QoL-AD, and that it can be used as a stand-alone measure 
of quality of life in dementia research.20 The effects of the 
current intervention may be of a nature that is difficult to 
capture. Certainly, the clinical reports on this trial indi-
cated that the usual dementia outcomes measures were 
unable to identify strong clinical changes.12 However, 
cardiorespiratory fitness and exercise self-efficacy 
improved significantly, and per-protocol analyses showed 
improvements in both single-task physical performance 
and dual-task performance.13 Some evidence suggests that 
the EQ-5D-5L instrument is more responsive to physical 
aspects of health in elderly, whereas DEMQOL is more 
responsive to cognitive changes.24 Perhaps concurrent 
use of multiple HRQoL instruments may aid in capturing 
the full effect of exercise interventions.
The outcomes measured by the EQ instrument indi-
cated an incremental change of 0.007 using the EQ-5D-5L 
and 2.0 using the EQ-VAS. These mean measures hide the 
fact that some participants actually reported better health 
status at 16-week follow-up than at baseline, suggesting 
a health improvement and that some reported health 
deterioration or no change. It is unclear whether the 
observed changes would be within the range of minimal 
meaningful clinical difference.25–28
In the analysis, participants who fully complied with 
the exercise intervention the outcomes appeared to 
be better in comparison with the whole control group 
(figure 5). However, the intervention may have a positive 
lasting effect on the objectives of preserving cognition, 
improving quality of life, physical health and functional 
abilities—which may not be captured by the EQ-5D-5L 
instrument. If this is the case, then the effects of the 
intervention are underestimated. It is also important 
to recognise that participants of this study were willing 
and able to participate in intensive exercise, which may 
not be representative of the general AD population. It is 
possible, that this programme may be more beneficial for 
people with lower levels of cognitive impairment or more 
sedentary lifestyles.
Proxy measurements
Due to the cognitive impairment of dementia, it may 
be difficult to obtain self-completed measurement and, 
indeed, to trust the validity of the self-completed measure-
ments. Therefore, it is common practice to obtain proxy 
measurements from caregivers on behalf of participants. 
This raises the issues as to what extent caregivers are 
able to validly assess the health status of the participants, 
and how to handle possible discrepancies between the 
responses by the participants and proxy respondents.29 30
It appears that the probability that the intervention is 
cost-effective in comparison with the control is higher 
when using participant assessments than the caregiver 
assessment (figure 4). It is interesting to note in the 
per-protocol analysis of participants, who fully complied 
with the exercise intervention that the CEACs using the 
caregiver-reported health status appeared to indicate 
substantial lower probability for cost-effectiveness than 
the participant-reported health status (figure 5). This 
may need further exploration.
Valuation of respite from care
In the analysis where the value of caregivers’ respite was 
used to offset the cost of the intervention, a fairly low 
time value (below €10/hour) indicated that there was a 
high probability that the intervention would be cheaper 
and more effective (figure 6). However, when a positive 
value was assigned to an EQ gain, the probability of the 
intervention being cost-effective reduced. This relates 
to the fact that not all participants in the exercise group 
achieved a gain in EQ score and, thus, the saving from the 
intervention cost and value of respite from the caring task 
should be off-set by the apparent loss in EQ score.
conclusIon and PersPecTIves
The trial design with randomisation to control and inter-
vention group and the availability of nearly complete data 
are the main strengths of the study. The cost-effectiveness 
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analysis was conducted using standard analytical meth-
odologies and has tested the consequences of different 
methodological challenges.
The relatively short time perspective and perhaps lack 
of data about the cost consequences of health and social 
care are potential weaknesses. If the effect of the interven-
tion is expected to last for a period beyond the 16 weeks 
follow-up, then the outcomes might be underestimated, 
and thus the probability of the intervention being cost-ef-
fective might be underestimated.
In future studies, the longer term effects in terms of 
additional resource use and longer term health improve-
ment might be considered.
This analysis suggests that the exercise intervention 
may not be cost-effective under commonly used threshold 
values for health gains. This would indicate that munici-
palities, who are responsible for providing rehabilitation 
services to people with dementia, should consider ways 
of providing the intervention at a lower cost or, perhaps, 
to a more targeted group. One concern that might espe-
cially be addressed is how such a programme may achieve 
such high completion rates as was obtained in this study. 
When implemented in daily practice, such rates may be 
expected to reduce as the target group will be expanded 
and thus include individuals who are less motivated for 
physical exercise or are less supported for such activities 
by their caregiver.
Author affiliations
1Center of Health Economic Research, Institute of Public Health, University of 
Southern Denmark, Odense, Denmark
2Healthcare Outcomes Research Centre, The Royal College of Surgeons in Ireland, 
Dublin, Ireland
3Department of Physical and Occupational Therapyand Institute of Sports Medicine, 
Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, 
Denmark
4Danish Dementia Research Centre, Rigshospitalet, University of Copenhagen, 
Copenhagen, Denmark
Correction notice This paper has been amended since it was published Online 
First. Owing to a scripting error, some of the publisher names in the references 
were replaced with 'BMJ Publishing Group'. This only affected the full text version, 
not the PDF. We have since corrected theseerrors and the correct publishers have 
been inserted into the references.
Acknowledgements We are thankful to all the physical therapists, nurses, clinical 
raters and investigators for their contributions to the ADEX study. Memory clinic 
investigators: Birgitte Bo Andersen, MD, DMSc, , Dept. of Neurology, Rigshospitalet 
(Blegdamsvej), University of Copenhagen; Peter Høgh, PhD, MD, Roskilde Hospital 
Memory Clinic; Vestergaard, MD, Aalborg Hospital Karsten; Hans Brændgaard, 
MD Hanne Gottrup, PhD, MD, Aarhus University Hospital; Anette Lolk, Associate 
Professor, PhD, MD Lene Wermuth, MD, Dementia Clinic, Odense University 
Hospital; Søren Jakobsen, MD, Department of Geriatrics, OUH, Svendborg Hospital; 
Lars P Laugesen, MD Robert Graff Gergelyffy, MD, Department of Geriatrics, 
Slagelse Hospital; Eva Bjerregaard, MD,Dept. of Neurology, Rigshospitalet (Glostrup) 
University of Copenhagen
Contributors GW, SGH, NB contributed to the design of the trial. SGH was the 
principal investigator of the trial. NB was responsible for the physical assessments 
and the physical exercise intervention. JS conducted the economic analysis with 
help from ES. GW contributed to interpretation of the data. ES and JS drafted the 
paper. All authors participated in writing the paper, reviewed it for content and 
approved the final version.
Competing interests None declared.
Patient consent Not obtained.
Ethics approval Danish National Committee on Biomedical Research Ethics.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement Data is not available for sharing 
Open Access This is an Open Access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited and the use is non-commercial. See: http:// creativecommons. org/ 
licenses/ by- nc/ 4. 0/
© Article author(s) (or their employer(s) unless otherwise stated in the text of the 
article) 2017. All rights reserved. No commercial use is permitted unless otherwise 
expressly granted.
references
 1. Sundhedsstyrelsen MMT. Udredning og behandling af demens-en 
medicinsk teknologivurdering. København: Sundhedsstyrelsen, 
Monitorering & Medicinsk Teknologivurdering, 2008.
 2. Law LL, Barnett F, Yau MK, et al. Effects of functional tasks 
exercise on older adults with cognitive impairment at risk of 
Alzheimer's disease: a randomised controlled trial. Age Ageing 
2014;43:813–20.
 3. Vreugdenhil A, Cannell J, Davies A, et al. A community-based 
exercise programme to improve functional ability in people with 
Alzheimer's disease: a randomized controlled trial. Scand J Caring 
Sci 2012;26:12–19.
 4. Öhman H, Savikko N, Strandberg TE, et al. Effects of exercise on 
cognition: the finnish alzheimer disease exercise trial: a randomized, 
controlled trial. J Am Geriatr Soc 2016;64:731–8.
 5. Pitkälä KH, Pöysti MM, Laakkonen ML, et al. Effects of the Finnish 
Alzheimer disease exercise trial (FINALEX): a randomized controlled 
trial. JAMA Intern Med 2013;173:894–901.
 6. Davis JC, Bryan S, Marra CA, et al. An economic evaluation of 
resistance training and aerobic training versus balance and toning 
exercises in older adults with mild cognitive impairment. PLoS One 
2013;8:e63031.
 7. EuroQol Group. EuroQol--a new facility for the measurement of 
health-related quality of life. Health Policy 1990;16:199–208.
 8. Drummond MF, Sculpher M, Torrance GW, et al; Methods for the 
economic evaluation of health care programmes. Oxford: Oxford 
University Press, 2016.
 9. Wimo A, Jönsson B, Karlsson G, et al. Health economics of 
dementia. Wiley Chichester, 1998.
 10. Jönsson L, Andreasen N, Kilander L, et al. Patient- and proxy-
reported utility in Alzheimer disease using the EuroQoL. Alzheimer 
Dis Assoc Disord 2006;20:49–55.
 11. Hoffmann K, Frederiksen KS, Sobol NA, et al. Preserving cognition, 
quality of life, physical health and functional ability in Alzheimer's 
disease: the effect of physical exercise (ADEX trial): rationale and 
design. Neuroepidemiology 2013;41(3-4):198–207.
 12. Hoffmann K, Sobol NA, Frederiksen KS, et al. Moderate-to-high 
intensity physical exercise in patients with alzheimer's disease: a 
randomized controlled trial. J Alzheimers Dis 2016;50:443–53.
 13. Sobol NA, Hoffmann K, Frederiksen KS, et al. Effect of aerobic 
exercise on physical performance in patients with Alzheimer's 
disease. Alzheimers Dement 2016;12:1207–15.
 14. Wittrup-Jensen KU, Lauridsen J, Gudex C, et al. Generation of a 
Danish TTO value set for EQ-5D health states. Scand J Public Health 
2009;37:459–66.
 15. Gc V, Wilson EC, Suhrcke M, et al. Are brief interventions to increase 
physical activity cost-effective? A systematic review. Br J Sports 
Med 2016;50:408–17.
 16. Knapp M. Economic evaluation and mental health: sparse past. 
fertile future? J Ment Health Policy Econ 1999;2:163–7.
 17. Knapp M. The cost-effectiveness challenge: is it worth it? Alzheimers 
Res Ther 2015;7:10.
 18. GC V, Wilson EC, Suhrcke M, Vijay GC, al E, et al. Are brief 
interventions to increase physical activity cost-effective? A 
systematic review. Br J Sports Med 2016;50:408–17.
 19. Davis JC, Bryan S, Marra CA, et al. Challenges with cost-utility 
analyses of behavioural interventions among older adults at risk for 
dementia. Br J Sports Med 2015;49:1343–7.
 20. Aguirre E, Kang S, Hoare Z, et al. How does the EQ-5D perform 
when measuring quality of life in dementia against two other 
dementia-specific outcome measures? Qual Life Res 2016;25:45–9.
group.bmj.com on March 28, 2018 - Published by http://bmjopen.bmj.com/Downloaded from 
 11Sopina E, et al. BMJ Open 2017;7:e015217. doi:10.1136/bmjopen-2016-015217
Open Access
 21. Hounsome N, Orrell M, Edwards RT. EQ-5D as a quality of life 
measure in people with dementia and their carers: evidence and key 
issues. Value Health 2011;14:390–9.
 22. Kunz S. Psychometric properties of the EQ-5D in a study of people 
with mild to moderate dementia. Qual Life Res 2010;19:425–34.
 23. Orgeta V, Edwards RT, Hounsome B, et al. The use of the EQ-5D as a 
measure of health-related quality of life in people with dementia and 
their carers. Qual Life Res 2015;24:315–24.
 24. Ratcliffe J, Flint T, Easton T, et al. An empirical comparison of the EQ-
5D-5L, DEMQOL-U and DEMQOL-Proxy-U in a post-hospitalisation 
population of frail older people living in residential aged care. Appl 
Health Econ Health Policy 2016;51:1.
 25. Chen P, Lin KC, Liing RJ, et al. Validity, responsiveness, and minimal 
clinically important difference of EQ-5D-5L in stroke patients 
undergoing rehabilitation. Qual Life Res 2016;25:1585–96.
 26. Coretti S, Ruggeri M, McNamee P. The minimum clinically 
important difference for EQ-5D index: a critical review. Expert Rev 
Pharmacoecon Outcomes Res 2014;14:221–33.
 27. Kohn CG, Sidovar MF, Kaur K, et al. Estimating a minimal clinically 
important difference for the EuroQol 5-Dimension health status 
index in persons with multiple sclerosis. Health Qual Life Outcomes 
2014;12:66.
 28. Zanini A, Aiello M, Adamo D, et al. Estimation of minimal clinically 
important difference in EQ-5D visual analog scale score after 
pulmonary rehabilitation in subjects with COPD. Respir Care 
2015;60:88–95.
 29. Arons AM, Krabbe PF, Schölzel-Dorenbos CJ, et al. Quality of 
life in dementia: a study on proxy bias. BMC Med Res Methodol 
2013;13:110.
 30. Coucill W, Bryan S, Bentham P, et al. EQ-5D in patients with 
dementia: an investigation of inter-rater agreement. Med Care 
2001;39:760–71.
group.bmj.com on March 28, 2018 - Published by http://bmjopen.bmj.com/Downloaded from 
measures in Denmark
proxy-reported health-related quality of life 
secondary analysis exploring patient and
physical activity in Alzheimer's disease: a 
Cost-effectiveness of a randomised trial of
and Gunhild Waldemar
Elizaveta Sopina, Jan Sørensen, Nina Beyer, Steen Gregers Hasselbalch
doi: 10.1136/bmjopen-2016-015217
2017 7: BMJ Open
 http://bmjopen.bmj.com/content/7/6/e015217
Updated information and services can be found at: 
These include:
References
 http://bmjopen.bmj.com/content/7/6/e015217#ref-list-1
This article cites 27 articles, 4 of which you can access for free at: 
Open Access
 http://creativecommons.org/licenses/by-nc/4.0/non-commercial. See: 
provided the original work is properly cited and the use is
non-commercially, and license their derivative works on different terms, 
permits others to distribute, remix, adapt, build upon this work
Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
This is an Open Access article distributed in accordance with the Creative
service
Email alerting
box at the top right corner of the online article. 
Receive free email alerts when new articles cite this article. Sign up in the
Collections
Topic Articles on similar topics can be found in the following collections 
 (393)Health economics
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on March 28, 2018 - Published by http://bmjopen.bmj.com/Downloaded from 
